Posted on June 6, 20256/6/25
Comparing Long-Term HAE Treatments: Insights from a Robust Network Meta-Analysis
Posted on May 23, 20255/23/25
Most Favored Nation Pricing | Insights and Implications for Manufacturers
Posted on May 22, 20255/22/25
Demystifying Market Access: A Must-Read for Navigating the Lab-to-Patient Journey
Posted on May 21, 20255/21/25
EVERSANA Returns as Global Host and Presenting Sponsor for Frontiers Health 2025
Posted on May 15, 20255/15/25
Staying Ahead of the Curve in Pharmacovigilance: CIOMS XIV Draft “Artificial Intelligence in Pharmacovigilance”
Posted on May 15, 20255/15/25
Staying Ahead of the Curve in Pharmacovigilance: Outcome of GVP Inspections by NPRA
Posted on May 5, 20255/5/25
Staying Ahead of the Curve in Pharmacovigilance: Emerging Regulations and Their Implications in Saudi Arabia
Posted on April 10, 20254/10/25
Unlock the Power of Indirect Treatment Comparisons (ITC) with Industry Experts
Posted on April 3, 20254/3/25